220 related articles for article (PubMed ID: 18400079)
1. Antiretroviral drug resistance among antiretroviral-naïve persons with recent HIV infection in Thailand.
Apisarnthanarak A; Jirayasethpong T; Sa-nguansilp C; Thongprapai H; Kittihanukul C; Kamudamas A; Tungsathapornpong A; Mundy LM
HIV Med; 2008 May; 9(5):322-5. PubMed ID: 18400079
[TBL] [Abstract][Full Text] [Related]
2. Secure antiretroviral therapy delivery in a resource-limited setting: streamlined to minimize drug resistance and expense.
Kitkungvan D; Apisarnthanarak A; Laowansiri P; Mundy LM
HIV Med; 2008 Oct; 9(8):636-41. PubMed ID: 18643857
[TBL] [Abstract][Full Text] [Related]
3. HIV-1 drug resistance in Thailand: before and after National Access to Antiretroviral Program.
Sutthent R; Arworn D; Kaoriangudom S; Chokphaibulkit K; Chaisilwatana P; Wirachsilp P; Thiamchai V; Sirapraphasiri T; Tanprasertsuk S
J Clin Virol; 2005 Dec; 34(4):272-6. PubMed ID: 16286051
[TBL] [Abstract][Full Text] [Related]
4. The impacts of current antiretroviral therapy regimens on Chinese AIDS patients and their implications for HIV-1 drug resistance mutation.
Zhang M; Han XX; Cui WG; Jia MH; Meng XD; Xing AH; Wu YH; Yang YY; Lu CM; Hu QH; Dai D; Zhang ZN; Shang H
Jpn J Infect Dis; 2008 Sep; 61(5):361-5. PubMed ID: 18806342
[TBL] [Abstract][Full Text] [Related]
5. HIV drug resistance transmission threshold survey in Bangkok, Thailand.
Sirivichayakul S; Phanuphak P; Pankam T; O-Charoen R; Sutherland D; Ruxrungtham K
Antivir Ther; 2008; 13 Suppl 2():109-13. PubMed ID: 18575199
[TBL] [Abstract][Full Text] [Related]
6. Genetic diversity and drug resistance mutations in HIV type 1 from untreated patients in Bamako, Mali.
Derache A; Traore O; Koita V; Sylla A; Tubiana R; Simon A; Canestri A; Carcelain G; Katlama C; Calvez V; Cisse M; Marcelin AG
Antivir Ther; 2007; 12(1):123-9. PubMed ID: 17503757
[TBL] [Abstract][Full Text] [Related]
7. Surveillance of genotypic resistance mutations in chronic HIV-1 treated individuals after completion of the National Access to Antiretroviral Program in Thailand.
Sukasem C; Churdboonchart V; Chasombat S; Kohreanudom S; Watitpun C; Pasomsub E; Piroj W; Tiensuwan M; Chantratita W
Infection; 2007 Apr; 35(2):81-8. PubMed ID: 17401711
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of a generic fixed-dose combination of stavudine, lamivudine and nevirapine (GPO-VIR) in Thai HIV-infected patients.
Kiertiburanakul S; Khongnorasat S; Rattanasiri S; Sungkanuparph S
J Med Assoc Thai; 2007 Feb; 90(2):237-43. PubMed ID: 17375626
[TBL] [Abstract][Full Text] [Related]
9. Trends of antiretroviral drug resistance in treatment-naive patients with human immunodeficiency virus type 1 infection in Taiwan.
Chang SY; Chen MY; Lee CN; Sun HY; Ko W; Chang SF; Chang KL; Hsieh SM; Sheng WH; Liu WC; Wu CH; Kao CL; Hung CC; Chang SC
J Antimicrob Chemother; 2008 Mar; 61(3):689-93. PubMed ID: 18227088
[TBL] [Abstract][Full Text] [Related]
10. The prevalence of transmitted antiretroviral drug resistance in treatment-naïve patients and factors influencing first-line treatment regimen selection.
Huang HY; Daar ES; Sax PE; Young B; Cook P; Benson P; Cohen C; Scribner A; Hu H
HIV Med; 2008 May; 9(5):285-93. PubMed ID: 18400075
[TBL] [Abstract][Full Text] [Related]
11. Plasma nevirapine levels and 24-week efficacy of a fixed-dose combination of stavudine, lamivudine and nevirapine (GPO-VIR) among Thai HIV-infected patients.
Manosuthi W; Kiertiburanakul S; Chaovavanich A; Sungkanuparph S
J Med Assoc Thai; 2007 Feb; 90(2):244-50. PubMed ID: 17375627
[TBL] [Abstract][Full Text] [Related]
12. Demographic, socio-economic, behavioral and clinical factors predicting virologic failure with generic fixed-dose combination antiretroviral therapy before universal health insurance coverage in northern Thailand.
Tsuchiya N; Pathipvanich P; Yasuda T; Mukoyama Y; Rojanawiwat A; Matsubayashi T; Saeng-aroon S; Auwanit W; Matsuyama A; Sawanpanyalert P; Ariyoshi K
Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):71-82. PubMed ID: 19323037
[TBL] [Abstract][Full Text] [Related]
13. Antiretroviral drug resistance surveillance among drug-naive HIV-1-infected individuals in Gauteng Province, South Africa in 2002 and 2004.
Pillay V; Ledwaba J; Hunt G; Rakgotho M; Singh B; Makubalo L; Bennett DE; Puren A; Morris L
Antivir Ther; 2008; 13 Suppl 2():101-7. PubMed ID: 18575198
[TBL] [Abstract][Full Text] [Related]
14. High rate of early virological failure with the once-daily tenofovir/lamivudine/nevirapine combination in naive HIV-1-infected patients.
Rey D; Hoen B; Chavanet P; Schmitt MP; Hoizey G; Meyer P; Peytavin G; Spire B; Allavena C; Diemer M; May T; Schmit JL; Duong M; Calvez V; Lang JM
J Antimicrob Chemother; 2009 Feb; 63(2):380-8. PubMed ID: 19036752
[TBL] [Abstract][Full Text] [Related]
15. Predictive factors of antiretroviral (ARV) drug adherence among people living with HIV/AIDS attending at Taksin Hospital, Bangkok, Thailand.
Chamroonsawasdi K; Insri N; Pitikultang S
J Med Assoc Thai; 2011 Jul; 94(7):775-81. PubMed ID: 21774282
[TBL] [Abstract][Full Text] [Related]
16. Infrequent transmission of HIV-1 drug-resistant variants.
Yerly S; Jost S; Telenti A; Flepp M; Kaiser L; Chave JP; Vernazza P; Battegay M; Furrer H; Chanzy B; Burgisser P; Rickenbach M; Gebhardt M; Bernard MC; Perneger T; Hirschel B; Perrin L;
Antivir Ther; 2004 Jun; 9(3):375-84. PubMed ID: 15259900
[TBL] [Abstract][Full Text] [Related]
17. Women exposed to single-dose nevirapine in successive pregnancies: effectiveness and nonnucleoside reverse transcriptase inhibitor resistance.
Martinson NA; Morris L; Johnson J; Gray GE; Pillay V; Ledwaba J; Dhlamini P; Cohen S; Puren A; Steyn J; Heneine W; McIntyre JA
AIDS; 2009 Apr; 23(7):809-16. PubMed ID: 19287298
[TBL] [Abstract][Full Text] [Related]
18. Genotypic resistance mutations in treatment-naïve and treatment-experienced patients under widespread use of antiretroviral drugs in Thailand: implications for further epidemiologic surveillance.
Sukasem C; Churdboonchart V; Sirisidthi K; Riengrojpitak S; Chasombat S; Watitpun C; Piroj W; Tiensuwan M; Chantratita W
Jpn J Infect Dis; 2007 Sep; 60(5):284-9. PubMed ID: 17881868
[TBL] [Abstract][Full Text] [Related]
19. Transmitted drug-resistant HIV-1 in primary HIV-1 infection; incidence, evolution and impact on response to antiretroviral therapy.
Fox J; Dustan S; McClure M; Weber J; Fidler S
HIV Med; 2006 Oct; 7(7):477-83. PubMed ID: 16925735
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of fixed-dose combination stavudine, lamivudine and nevirapine (GPO-VIR) for treatment of naïve HIV patients in Thailand: a 3-year follow-up.
Desakorn V; Karmacharya BM; Thanachartwet V; Kyaw NL; Tansuphaswadikul S; Sahassananda D; Dhitavat J; Maek-a-nantawat W; Pitisuttithum P
Southeast Asian J Trop Med Public Health; 2011 Nov; 42(6):1414-22. PubMed ID: 22299411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
